Late development of resistance to BRAF/MEK inhibitors in malignant melanoma: a case report

被引:0
|
作者
Adam, C. [1 ]
Meier, F. [1 ]
Garzarolli, M. [1 ]
机构
[1] Uniklinikum Dresden, Dresden, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
eP085
引用
收藏
页码:81 / 81
页数:1
相关论文
共 50 条
  • [21] Recent advances in the treatment of melanoma with BRAF and MEK inhibitors
    Munoz-Couselo, Eva
    Soberino Garcia, Jesus
    Manuel Perez-Garcia, Jose
    Ortega Cebrian, Vanesa
    Cortes Castan, Javier
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (15)
  • [22] A second chance for success with BRAF and MEK inhibitors in melanoma
    Paulson, Kelly G.
    Thompson, John A.
    LANCET ONCOLOGY, 2017, 18 (04): : 418 - 419
  • [23] Integrating BRAF/MEK inhibitors into combination therapy for melanoma
    Smalley, K. S. M.
    Flaherty, K. T.
    BRITISH JOURNAL OF CANCER, 2009, 100 (03) : 431 - 435
  • [24] Empiric Therapy with BRAF and MEK Inhibitors in Metastatic Melanoma
    Cann, Christopher G.
    Tillman, Benjamin F.
    Davis, Elizabeth J.
    Johnson, Douglas B.
    ONCOLOGIST, 2019, 24 (11): : 1495 - 1496
  • [25] Challenges in the treatment of melanoma with BRAF and MEK inhibitors in patients with sickle cell disease: case report and review of the literature
    Diamantopoulos, Panagiotis T.
    Anastasopoulou, Amalia
    Dimopoulou, Maria
    Samarkos, Michalis
    Gogas, Helen
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [26] Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma A case report
    Maanaoui, Mehdi
    Saint-Jacques, Camille
    Gnemmi, Viviane
    Frimat, Marie
    Lionet, Arnaud
    Hazzan, Marc
    Noel, Christian
    Provot, Francois
    MEDICINE, 2017, 96 (25)
  • [27] Bilateral multifocal central serous retinopathy due to management of metastatic melanoma with BRAf MEK inhibitors: Case report
    Patel, Grisma
    Edirisooriya, Monisha
    Dey, Moloy
    Parkar, Rosemeen
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2023, 9
  • [28] Case report: Parsonage-turner syndrome in a melanoma patient treated by BRAF/MEK inhibitors after immune checkpoint inhibitors
    Bonnefin, Charlotte
    Duval, Fanny
    Rouanet, Marie
    Kostine, Marie
    Gerard, Emilie
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [29] IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma
    Patel, Hima
    Mishra, Rosalin
    Yacoub, Nour
    Alanazi, Samar
    Kilroy, Mary Kate
    Garrett, Joan T.
    CANCERS, 2021, 13 (22)
  • [30] Case report: A case of metastatic BRAFV600-mutated melanoma with heart failure treated with immune checkpoint inhibitors and BRAF/MEK inhibitors
    Nishizawa, Aya
    Kawakami, Misaki
    Kitahara, Yasuyuki
    FRONTIERS IN ONCOLOGY, 2024, 14